William Pate, Director at Adams Respiratory Therapeutics, Inc. (ARXT), sold 2,000 shares at $44.88 ($90K) on 2007-02-01, disclosed to the SEC on 2007-02-05.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PARR | SELL | 2023-11-29 | $7.8M | — | Filing → |
| PARR | SELL | 2023-08-15 | $8.0M | — | Filing → |
| PARR | BUY | 2021-12-20 | $929K | — | Filing → |